Commodity Supercycl...
Health Care: Drugs
Durect Corporation (DRRX: NASDAQ)
$0.91 -0.04 | -4.38%
05/22/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 0 | 100,000 | 173,454 | 173,454 | 86,264 | 12,810 | 32,810 |
| Shares Bought | 0 | 100,000 | 173,454 | 173,454 | 86,264 | 12,810 | 32,810 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 49.46M | 48.06M | 48.12M | 47.33M | 42.13M | 39.68M | 36.79M |
| Shares Bought | 9.24M | 15.36M | 16.11M | 15.30M | 9.13M | 6.87M | 6.51M |
| Shares Sold | 3.64M | 6.76M | 7.12M | 7.12M | 3.79M | 3.89M | 3.04M |
Portfolios with DRRX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ProRobert Bruce
- Userdonellisor
- UserTrading
- Userbaustin002 Portfolio 1
- UserBarron's Research Reports 1...
Latest DRRX Headlines from TheStreet
- Durect Corporation Stock Downgraded (DRRX) 05.07.13 | 05:05 am
- 4 Stocks Under $5 Moving Higher 03.19.13 | 03:03 pm
- 4 Stocks Under $5 Making Big Moves 02.26.13 | 02:02 pm
- 5 Stocks Setting Up to Break Out 01.25.13 | 01:01 pm
- 8 Stocks Under $10 Making Big Moves 08.30.12 | 02:08 pm
- Durect Corporation Stock Upgraded (DRRX) 07.24.12 | 05:07 am
- Alkermes Needs to Build on Drug Delivery Success 06.18.12 | 07:06 am
- Business Highlights 06.24.11 | 06:06 pm
- Durect Stock Gaps Down On Today's Open (DRRX) 06.24.11 | 09:06 am
- Pfizer, Pain Therapeutics Drug Rejected by FDA 06.24.11 | 08:06 am
Press Releases for DRRX
- DURECT Announces Update On Remoxy® - PR Newswire 05.10.13 | 07:05 am
- DURECT Corporation Invites You To Join Its First Quarter 2013 Earnings Conference Call - PR Newswire 04.24.13 | 08:04 am
- DURECT Announces Submission Of New Drug Application For POSIDUR⿢ (SABER®-Bupivacaine) - PR Newswire 04.16.13 | 07:04 am
- DURECT Corporation Invites You To Join Its Fourth Quarter 2012 Earnings Conference Call - PR Newswire 02.22.13 | 08:02 am
- DURECT To Participate In Upcoming Healthcare Conferences - PR Newswire 02.05.13 | 08:02 am
- DURECT Announces Positive Results From Reldayâ¿¢ Phase 1 Clinical Trial - PR Newswire 01.03.13 | 07:01 am
- DURECT Announces Pricing Of Public Offering Of Common Stock - PR Newswire 12.06.12 | 07:12 am
- DURECT To Participate In Upcoming Healthcare Conferences - PR Newswire 11.13.12 | 09:11 am
- DURECT Corporation Invites You To Join Its Third Quarter 2012 Earnings Conference Call - PR Newswire 10.30.12 | 04:10 pm
- DURECT To Participate In Upcoming Healthcare Conferences - PR Newswire 08.21.12 | 08:08 am
Partner Headlines for DRRX
- A Study Of 3 Biotechs - A Story Of Hope, Potential And Partnerships - Seeking Alpha 03.18.13 | 09:03 am
- Durect Offers Two Shots On Goal, Almost 100% Upside - Seeking Alpha 02.26.13 | 09:02 am
- 3 Best Biotech Stocks For This Week (Part V) - Seeking Alpha 10.08.12 | 09:10 am
- DRRX - Initiating Coverage of DURECT Corp. - Analyst Blog - NASDAQ 09.11.12 | 02:09 pm
- Benzinga's Microcap Movers for Friday July 20, 2012 - Benzinga 07.21.12 | 05:07 pm
- Pfizer Terminates Development and License Agreement Between Alpharma Ireland and DURECT - Benzinga 03.01.12 | 04:03 pm
- DURECT Announces Top-line Data from BESST; Did Not Reach Statistical Significance - Benzinga 01.05.12 | 04:01 pm
- 12 Healthcare Companies Looking at June Catalysts - Seeking Alpha 05.30.11 | 04:05 am
- Jefferies Reiterates Buy Rating on DURECT Corp. (DRRX) - Benzinga 08.05.10 | 09:08 am
- FDA Clears Hospira's Generic Drug - Analyst Blog - Zacks 06.25.10 | 01:06 pm
